Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Hemophilia A × Factor VIII × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2 Lymphoid 1

Conditions

Hemophilia A 2 Lymphoma, Follicular 1

Interventions

emicizumab 4 Factor VIII 2 recombinant FVIIa 1 anti-inhibitor coagulant complex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02847637 2022-11-16

HAVEN 3

Hoffmann-La Roche

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

NCT00037544 2008-04-22

Study Evaluating ReFacto AF in Severe Hemophilia A

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 3 Completed

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡